Yes, that could be also good explanation. I assume also that China, India etc. have completely different genetic population than europe populationes. This is important at clinical trials or bioequivalence study because some drugs substances could work differently for peoples form Asia and Europe. Pharma companies run trailes e.g in China and sell drugs only for regional area (because it work) this drug will be ineffective in Europe or could to do more damage.